Insider Trading March 30, 2026

Advanced Flower Capital Director Increases Stake with $62,475 Purchase

Leonard Tannenbaum adds 24,029 shares as the company posts a notable fourth-quarter earnings shortfall

By Marcus Reed AFCG
Advanced Flower Capital Director Increases Stake with $62,475 Purchase
AFCG

Director Leonard Tannenbaum bought 24,029 shares of Advanced Flower Capital Inc. (AFCG) on March 26 and 27, 2026, paying $2.60 per share for a total of $62,475. The transactions raised his direct holdings to 6,397,135 shares. The purchase comes amid a recent quarterly earnings miss and a stock trading near $2.64, roughly 50% below its level a year ago.

Key Points

  • Director Leonard Tannenbaum bought 24,029 AFCG shares on March 26-27, 2026, paying $2.60 per share for a total of $62,475.
  • Tannenbaum's direct holdings rose to 6,397,135 shares; he also indirectly holds 218,907 shares via his spouse and 180,400 through the Tannenbaum Family Foundation.
  • Advanced Flower Capital reported Q4 2025 EPS of -$0.12 versus an expected $0.03 and revenue of $5.19 million versus an expected $5.46 million; the stock traded at $2.64, down nearly 50% over the past year.

Leonard Tannenbaum, a director at Advanced Flower Capital Inc. (NASDAQ: AFCG), increased his direct stake in the company with purchases executed on March 26 and March 27, 2026. Across the two transactions he acquired 24,029 shares at $2.60 per share, bringing the total value of the buys to $62,475.

Following the trades, Tannenbaum's direct ownership in Advanced Flower Capital stands at 6,397,135 shares. The filings also indicate additional indirect holdings tied to Tannenbaum: 218,907 shares are reported as held by his spouse and 180,400 shares are attributed to the Tannenbaum Family Foundation.

The insider purchases arrive while AFCG's market price is quoted at $2.64 and the stock has declined nearly 50% over the past 12 months. Market-data referenced in company information shows a Price/Book ratio of 0.35, a metric described as reflecting an apparent undervaluation at current levels. Alongside that valuation signal, InvestingPro Tips note that AFCG produced strong returns over the last month and that this observation is one of more than eight additional tips available to subscribers of that service.

Investors are also contending with recent operating results. Advanced Flower Capital reported fourth-quarter 2025 results that fell short of analyst forecasts. The company recorded earnings per share of -$0.12 compared with a consensus estimate of $0.03, a shortfall characterized in the report as a -500% surprise relative to expectations. Revenue for the quarter was $5.19 million, below the anticipated $5.46 million.

Despite the earnings and revenue misses, the company's shares registered a slight increase in pre-market trading following the release of the fourth-quarter results. The combination of insider buying, depressed share price relative to last year, and the most recent quarterly disappointments frames a complex picture for market participants evaluating AFCG's near-term prospects.


Summary

Leonard Tannenbaum purchased 24,029 shares of Advanced Flower Capital at $2.60 per share on March 26 and 27, 2026, increasing his direct holdings to 6,397,135 shares. The company reported a Q4 2025 EPS of -$0.12 versus an expected $0.03 and revenue of $5.19 million against a $5.46 million projection. AFCG shares traded at $2.64 and are down nearly 50% year-over-year, while InvestingPro data indicates a Price/Book of 0.35 and InvestingPro Tips flag recent strong monthly returns.

Risks

  • Recent quarterly results missed analyst forecasts on both EPS and revenue, indicating near-term operational challenges - this affects equity investors and market valuation.
  • The stock has declined nearly 50% over the past year, reflecting sustained downward pressure that could continue to influence investor sentiment and liquidity.
  • Valuation and short-term performance signals are mixed: a low Price/Book multiple suggests potential undervaluation while earnings and revenue misses create uncertainty for future performance.

More from Insider Trading

Photronics Director Sells $204k in PLAB, Exercises Options and Retains Majority Stake Mar 30, 2026 Impact Biomedical CFO Disposes $25,330 in IBO Shares Across Two Trades Mar 30, 2026 Control Empresarial trims Talos Energy stake with $38.54 million share sale Mar 30, 2026 PBF Energy SVP Sells $2.57M in Stock After Exercising Long‑standing Options Mar 30, 2026 22NW Entities Trim Stake in L.B. Foster; Sale Coincides With Mixed Q4 2025 Results Mar 30, 2026